Clearmind Medicine Inc (CMND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
| 10-2022 | 09-2022 | 07-2022 | 06-2022 | 04-2022 | |
| Operating Expenses | 0 | 0 | 1,351 | 1,060 | 2,221 |
| Operating Income | N/A | N/A | -1,351 | -1,060 | -2,221 |
| Other Income | 0 | 0 | -132 | 0 | -105 |
| Pre-tax Income | 0 | 0 | -1,483 | -1,060 | -2,326 |
| Net Income Continuous | -1,435 | 0 | -1,483 | -2,326 | -2,326 |
| Net Income | $-1,435 | $0 | $-1,483 | $-2,326 | $-2,326 |
| EPS Basic Total Ops | -28,208.56 | N/A | -13,453.45 | N/A | -21,381.38 |
| EPS Basic Continuous Ops | -28,271.96 | N/A | -13,495.42 | N/A | -21,342.52 |
| EPS Diluted Total Ops | -28,208.56 | N/A | -13,453.45 | N/A | -21,381.38 |
| EPS Diluted Continuous Ops | -28,271.96 | N/A | -13,495.42 | N/A | -21,342.52 |
| EBITDA(a) | $7 | $24 | $-1,347 | $-1,060 | $-2,221 |